Different effect of CVVHDF and coupled plasma filtration and adsorption on IL-6 and procalcitonin in sepsis
Critical Care volume 15, Article number: P117 (2011)
A decrease of IL-6 and procalcitonin (PCT) correlates with survival during sepsis . Coupled plasma filtration and adsorption (CPFA) supports the renal function and removes proinflammatory mediators, but few clinical studies compare the effects of CPFA and CVVHDF, the standard of care in septic patients with renal failure . The aim of this study is to evaluate whether CPFA and CVVHD have a different effect on IL-6 and PCT in septic patients.
Seventy septic patients have been enrolled in this study. Fifty-five patients were submitted to CPFA. Every patient had four CPFA treatments (LINDA; Bellco-Mirandola, Italy) for 8 hours with Qb = 200 ml/minute, Q ultrafiltration = 30 ml/kg/hour and Q plasma = 20% of Qb. Fifteen septic patients submitted to CVVHDF were used as the control group. At T0 (basal), T1 (after 24 hours), T2 (after 76 hours), plasma IL-6 and plasma PCT was evaluated. ANOVA was used to compare changes during times study. P < 0.05 was considered statistically significant.
CPFA seems more efficient then CVVHDF to remove either IL-6 or PCT and to improve hemodynamic status. Further studies are warranted to show whether these data may translate into a better clinical outcome.
Nakada , et al.: Mol Med. 2008, 14: 257-263. 10.2119/2007-00108.Nakada
Lentini P, et al.: G Ital Nefrol. 2009, 6: 695-703.
About this article
Cite this article
Turani, F., Falco, M., Barchetta, R. et al. Different effect of CVVHDF and coupled plasma filtration and adsorption on IL-6 and procalcitonin in sepsis. Crit Care 15 (Suppl 1), P117 (2011). https://doi.org/10.1186/cc9537
- Public Health
- Clinical Outcome
- Clinical Study
- Renal Function
- Renal Failure